• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Depression App UpLift Raises $1M to Help People Fight Depression

by Jasmine Pennic 07/18/2019 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Depression App UpLift Raises $1M to Help People Fight Depression UpLift is the first mobile consumer app for depression to be based on a complete course of Cognitive Behavioral Therapy (CBT). The new round of funding will be used to accelerate UpLift’s development and improve core technology, while also building out newly requested features like an enhanced gamification system, the ability to connect with a coach, and more evidence-based and personalized activities to improve users’ mood.  

Cognitive Behavioral Therapy (CBT) Approach to Depression

UpLift includes twelve tailored “Sessions” and a toolkit of homework “Challenges,” all based on CBT, the most evidence-based psychological treatment in existence. Over the last two decades, computer-based CBT programs have shown to be effective in multiple meta-analyses. UpLift drastically improves upon these first-wave programs by being more interactive, more responsive to user needs, and by being the first available as a mobile app directly to consumers.

Pricing/Costs

Pricing for UpLift starts at $29.99 monthly or $14.99 a month quarterly at a 50% discount billed in 3-month increments. Users can cancel this account at any time.

Traction/Milestones to Date

To date, over 20,000 people have signed up for UpLift app. A recent pilot study with 120 participants found that users who completed the program had depression scores fall by 50% in one month, with improvements maintained 6 months later.

“These added resources are an important milestone on our mission to help 1 million people overcome depression.” says Eddie Liu, UpLift’s Co-founder and CEO, who is also the creator of MoodTools, an app for depression downloaded by over 1 million people. 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Depression

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |